Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted August 08, 2022
Seller of CBD Warned for COVID-19 Claims
On August 4, 2022, the FDA sent a warning letter to FluxxLab LLC following a review of the company’s website and social media which found statements about the company’s Covid-19 Immune Support Tincture and CBDA+CBD Oil Tincture products to be drug claims because they are intended to mitigate, prevent, treat, diagnose, or cure COVID-19 in people.
Join today to unlock all member benefits including full access to all recalls & warnings
Join NowAlready a member? Sign In Here.
Join now at www.consumerlab.com/join/